imipenem, anhydrous has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khalimov, ID; Krasin, VV; Latypov, AG; Potanin, AV; Potanin, VP; Sigal, EI; Sigal, RI; Taziev, RM | 1 |
1 other study(ies) available for imipenem, anhydrous and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
[Thienam treatment in early postoperative period after pneumonectomy in patients with lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Postoperative Care; Postoperative Complications; Time Factors | 2001 |